RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

RA-MAP, molecular immunological landscapes in early rheumatoid arthritis and healthy vaccine recipients

Rheumatoid arthritis (RA) is a chronic inflammatory disorder with poorly defined aetiology characterised by synovial inflammation with variable disease severity and drug responsiveness. To investigate the peripheral blood immune cell landscape of early, drug naive RA, we performed comprehensive clin...

Bibliografske podrobnosti
Main Authors:	Isaacs, JD, Brockbank, S, Pedersen, AW, Taylor, P, Buckley, C, Coles, M
Drugi avtorji:	The RA-MAP Consortium
Format:	Journal article
Jezik:	English
Izdano:	Nature Research 2022

Podobne knjige/članki

Bone turnover in early rheumatoid arthritis (RA)
od: Sambrook, P, et al.
Izdano: (1985)

T cell genetics and rheumatoid arthritis (RA)
od: Wordsworth, P
Izdano: (1998)

Rheumatoid arthritis: RA-lowering cardiovascular risk with statins
od: Lee, J, et al.
Izdano: (2010)

Rheumatoid arthritis: RA--lowering cardiovascular risk with statins.
od: Lee, J, et al.
Izdano: (2010)

Regulatory T cell immunological synapse in rheumatoid arthritis
od: Dustin, M
Izdano: (2016)

Interleukin 10 (IL-10) haplotypes are associated with rheumatoid arthritis (RA).
od: MacKay, K, et al.
Izdano: (2000)

The role of IL-10 in rheumatoid arthritis (RA) in two ethnically diverse populations.
od: MacKay, K, et al.
Izdano: (1999)

PARTICULAR GENETIC-VARIANTS OF TYPE-II COLLAGEN ARE NOT ASSOCIATED WITH RHEUMATOID-ARTHRITIS (RA)
od: Pile, K, et al.
Izdano: (1992)

TEMPORAL TRENDS IN THE TREATMENT OF RHEUMATOID ARTHRITIS (RA) IN THE UK WITH REFERENCE TO BEST PRACTICE
od: Edwards, C, et al.
Izdano: (2012)

Early environmental factors and rheumatoid arthritis.
od: Edwards, C, et al.
Izdano: (2006)

What is the role of fibroblasts in rheumatoid arthritis?
od: Buckley, C
Izdano: (2004)

Rapid and concurrent improvements in patient-reported outcomes of rheumatoid arthritis with baricitinib in RA-BEAM
od: Strand, V, et al.
Izdano: (2021)

Evolving the management of rheumatoid arthritis (eRA) through development of practical and educational tools
od: Van De Laar, M, et al.
Izdano: (2019)

Update on the diagnosis and management of early rheumatoid arthritis
od: Taylor, P
Izdano: (2020)

Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)
od: Maini, R, et al.
Izdano: (1995)

Development of an in-vitro rheumatoid arthritis (RA) model and its application in anti-rheumatic drug testing
od: Tan, Kian Siong
Izdano: (2016)

T-CELL RECEPTOR V-BETA-2 SEGMENT CODING POLYMORPHISM IS NOT ASSOCIATED WITH RHEUMATOID-ARTHRITIS (RA)
od: Pile, K, et al.
Izdano: (1993)

THE T-CELL RECEPTOR V-BETA-2 SEGMENT CODING POLYMORPHISM IS NOT ASSOCIATED WITH RHEUMATOID-ARTHRITIS (RA)
od: Cornelis, F, et al.
Izdano: (1992)

Influenza vaccines in healthy children.
od: Isaacs, D, et al.
Izdano: (2005)

Rheumatoid arthritis
od: Taylor, P
Izdano: (2022)

Rheumatoid arthritis.
od: Feldmann, M, et al.
Izdano: (1996)

Rheumatoid arthritis.
od: Wordsworth, P
Izdano: (1992)

HUMANIZED MONOCLONAL-ANTIBODY THERAPY IN RHEUMATOID-ARTHRITIS
od: Isaacs, J, et al.
Izdano: (1992)

Metabolic checkpoints in rheumatoid arthritis
od: Pucino, V, et al.
Izdano: (2020)

Developing multidisciplinary guidelines for the management of early rheumatoid arthritis.
od: Hennell, S, et al.
Izdano: (2008)

UPPER LIMB FUNCTIONAL DISABILITY IN EARLY RHEUMATOID ARTHRITIS
od: Adams, J, et al.
Izdano: (2004)

Targeting osteoporosis and rheumatoid arthritis by active vaccination against RANKL.
od: Spohn, G, et al.
Izdano: (2007)

Dysregulated immunologic landscape of early host response in melioidosis
od: Rongkard, P, et al.
Izdano: (2024)

Humanised monoclonal antibody therapy for rheumatoid arthritis.
od: Isaacs, J, et al.
Izdano: (1992)

Identification of a transitional fibroblast functional phenotype in very early rheumatoid arthritis
od: Filer, A, et al.
Izdano: (2017)

Immunology of vaccination.
od: Beverley, P
Izdano: (2002)

Cardiovascular risk factors and outcomes in early rheumatoid arthritis: a population-based study
od: Nikiphorou, E, et al.
Izdano: (2020)

Understanding the immunology of inflammatory arthritis
od: Taylor, P
Izdano: (2017)

QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries.
od: Sokka, T, et al.
Izdano: (2007)

A GENE INTERACTIVE WITH HLA-DR4 IN SUSCEPTIBILITY TO TYPE-I DIABETES IS NOT INVOLVED IN RHEUMATOID-ARTHRITIS (RA)
od: Pile, K, et al.
Izdano: (1992)

Remission and major clinical response in active rheumatoid arthritis (RA) patients after adalimumab (Humira (R)) treatment
od: Burmester, G, et al.
Izdano: (2007)

Achieving pain control in rheumatoid arthritis with baricitinib or ddalimumab plus methotrexate: Results from the RA-BEAM Trial
od: Taylor, P, et al.
Izdano: (2019)

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database.
od: Sokka, T, et al.
Izdano: (2009)

Models of rheumatoid arthritis.
od: Williams, R
Izdano: (2005)

Rheumatoid arthritis: introduction.
od: Feldmann, M, et al.
Izdano: (1998)